The purpose of this requirement is to provide outpatient hansen's disease services, which includes diagnosis, screening, outpatient treatment, case management, and follow-up care in healthcare…

Active Definitive Contract Awarded Last action

Contract number
75R60123C00003
Awardee
Awarding agency
Obligated
$413,852

Award facts

Opportunity
Contract value 68% obligated
  • $413,851.72 Current, with exercised options
  • $607,984.83 Potential, with all options
Completion date 62% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98104, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Exercise an Option P00007 $124,543
Other Administrative Action P00006 $0
Exercise an Option P00005 · NHDP172 C 4545: nhdp ambulatory care centers (ACC) harbor view, seattle WA $120,874
Change Order P00004 $0
Supplemental Agreement for work within scope P00003 $0
Funding Only Action P00002 $115,328
Exercise an Option P00001 $0
Original award $53,107

About this award

The National Hansen's Disease Program Clinical Research Center awarded a $607,984.83 definitive contract to Harborview Medical Center for outpatient Hansen's disease services on September 28, 2023, under a firm fixed-price structure with no set-aside.

The contract delivers diagnosis, screening, outpatient treatment, case management, and follow-up care for Hansen's disease patients in healthcare settings throughout the United States, with performance centered at Harborview Medical Center in Seattle, WA. The originating solicitation, posted February 1, 2023, sought multiple firm fixed-price contracts to continue the legislative mandate for Hansen's disease care historically provided through U.S. Public Health Service hospitals. The base period extends through September 27, 2028. Harborview Medical Center operates as a division of the University of Washington and serves as the only Level I adult and pediatric trauma and burn center in Washington state.

Description

The purpose of this requirement is to provide outpatient hansen's disease services, which includes diagnosis, screening, outpatient treatment, case management, and follow-up care in healthcare settings located throughout the united states.

Quick answers

Who was awarded contract 75R60123C00003?

75R60123C00003 was awarded to Harborview Medical Center by National Hansens Disease Program Clinical Research Center (Health Resources and Services Administration) on September 28, 2023.

How much is contract 75R60123C00003 worth?

The government has obligated $413,852 on 75R60123C00003. Its potential value, with all options, is $607,985.

Was contract 75R60123C00003 competed?

The extent of competition for 75R60123C00003 was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award